Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 35


Expression of a recombinant full-length LRP1B receptor in human non-small cell lung cancer cells confirms the postulated growth-suppressing function of this large LDL receptor family member.

Beer AG, Zenzmaier C, Schreinlechner M, Haas J, Dietrich MF, Herz J, Marschang P.

Oncotarget. 2016 Sep 8. doi: 10.18632/oncotarget.11897. [Epub ahead of print]


Acute myocardial infarction as a manifestation of systemic vasculitis.

Reindl M, Reinstadler SJ, Feistritzer HJ, Mayr A, Klug G, Marschang P, Metzler B.

Wien Klin Wochenschr. 2016 Sep 13. [Epub ahead of print]


Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis.

Bleker SM, van Es N, Kleinjan A, Büller HR, Kamphuisen PW, Aggarwal A, Beyer-Westendorf J, Camporese G, Cosmi B, Gary T, Ghirarduzzi A, Kaasjager K, Lerede T, Marschang P, Meijer K, Otten HM, Porreca E, Righini M, Verhamme P, van Wissen S, Di Nisio M.

J Thromb Haemost. 2016 May;14(5):973-81. doi: 10.1111/jth.13291. Epub 2016 Apr 4.


Impact of Whole Body Cryotherapy at -110 °C on Subjects with Arterial Hypertension.

Missmann M, Himsl M, Mur E, Ulmer H, Marschang P.

Arch Immunol Ther Exp (Warsz). 2016 Feb;64(1):75-82. doi: 10.1007/s00005-015-0363-9. Epub 2015 Sep 25.


Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ mice without influencing systemic atherosclerosis.

Theurl M, Schgoer W, Albrecht-Schgoer K, Lener D, Wolf D, Wolf M, Demetz E, Tymoszuk P, Tancevski I, Fischer-Colbrie R, Franz WM, Marschang P, Kirchmair R.

Cardiovasc Res. 2015 Jan 1;105(1):96-106. doi: 10.1093/cvr/cvu237. Epub 2014 Nov 5.


Safety and feasibility of a diagnostic algorithm combining clinical probability, d-dimer testing, and ultrasonography for suspected upper extremity deep venous thrombosis: a prospective management study.

Kleinjan A, Di Nisio M, Beyer-Westendorf J, Camporese G, Cosmi B, Ghirarduzzi A, Kamphuisen PW, Otten HM, Porreca E, Aggarwal A, Brodmann M, Guglielmi MD, Iotti M, Kaasjager K, Kamvissi V, Lerede T, Marschang P, Meijer K, Palareti G, Rickles FR, Righini M, Rutjes AW, Tonello C, Verhamme P, Werth S, van Wissen S, Büller HR.

Ann Intern Med. 2014 Apr 1;160(7):451-7. doi: 10.7326/M13-2056.


Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.

Hokusai-VTE Investigators, Büller HR, Décousus H, Grosso MA, Mercuri M, Middeldorp S, Prins MH, Raskob GE, Schellong SM, Schwocho L, Segers A, Shi M, Verhamme P, Wells P.

N Engl J Med. 2013 Oct 10;369(15):1406-15. doi: 10.1056/NEJMoa1306638. Epub 2013 Aug 31. Erratum in: N Engl J Med. 2014 Jan 23;370(4):390.


Oral apixaban for the treatment of acute venous thromboembolism.

Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Masiukiewicz U, Pak R, Thompson J, Raskob GE, Weitz JI; AMPLIFY Investigators.

N Engl J Med. 2013 Aug 29;369(9):799-808. doi: 10.1056/NEJMoa1302507. Epub 2013 Jul 1.


[Periprocedual management of vitamin K antagonist's with low molecular weight heparins during invasive procedures--Consensus of experts].

Watzke H, Metzler H, Weltermann A, Marschang P, Brodmann M, Lang W, Pabinger-Fasching I, Mahla E, Kozek-Langenecker S, Guschmann M, Huber K.

Wien Klin Wochenschr. 2013 Jul;125(13-14):412-20. German.


Apixaban for extended treatment of venous thromboembolism.

Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Porcari A, Raskob GE, Weitz JI; PLIFY-EXT Investigators.

N Engl J Med. 2013 Feb 21;368(8):699-708. doi: 10.1056/NEJMoa1207541. Epub 2012 Dec 8.


Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.

EINSTEIN–PE Investigators, Büller HR, Prins MH, Lensin AW, Decousus H, Jacobson BF, Minar E, Chlumsky J, Verhamme P, Wells P, Agnelli G, Cohen A, Berkowitz SD, Bounameaux H, Davidson BL, Misselwitz F, Gallus AS, Raskob GE, Schellong S, Segers A.

N Engl J Med. 2012 Apr 5;366(14):1287-97. doi: 10.1056/NEJMoa1113572. Epub 2012 Mar 26.


Prevalence of hypovitaminosis D and folate deficiency in healthy young female Austrian students in a health care profession.

Kaehler ST, Baumgartner H, Jeske M, Anliker M, Schennach H, Marschang P, Ratt A, Colvin AC, Falk J, Gasser A, Kirchebner J, Scherer C, Purtscher AE, Griesmacher A, Striessnig J.

Eur J Nutr. 2012 Dec;51(8):1021-31. doi: 10.1007/s00394-011-0281-5. Epub 2011 Nov 25.


LRP1b shows restricted expression in human tissues and binds to several extracellular ligands, including fibrinogen and apoE-carrying lipoproteins.

Haas J, Beer AG, Widschwendter P, Oberdanner J, Salzmann K, Sarg B, Lindner H, Herz J, Patsch JR, Marschang P.

Atherosclerosis. 2011 Jun;216(2):342-7. doi: 10.1016/j.atherosclerosis.2011.02.030. Epub 2011 Feb 24.


Oral rivaroxaban for symptomatic venous thromboembolism.

EINSTEIN Investigators, Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, Gallus AS, Lensing AW, Misselwitz F, Prins MH, Raskob GE, Segers A, Verhamme P, Wells P, Agnelli G, Bounameaux H, Cohen A, Davidson BL, Piovella F, Schellong S.

N Engl J Med. 2010 Dec 23;363(26):2499-510. doi: 10.1056/NEJMoa1007903. Epub 2010 Dec 3.


Symptomatic upper extremity deep vein thrombosis as a complication of ambulatory blood pressure monitoring.

Marschang P, Niederwanger A, Gasser RW, Daniaux M, Sturm W.

Thromb Haemost. 2008 Oct;100(4):711-2. No abstract available.


Dabigatran versus enoxaparin after total hip replacement.

Pechlaner C, Marschang P.

Lancet. 2007 Dec 15;370(9604):2002; author reply 2003-4. No abstract available.


Reduction of soluble P-selectin by statins is inversely correlated with the progression of coronary artery disease.

Marschang P, Friedrich GJ, Ditlbacher H, Stoeger A, Nedden DZ, Kirchmair R, Dienstl A, Pachinger O, Patsch JR.

Int J Cardiol. 2006 Jan 13;106(2):183-90.


Postprandial, but not postabsorptive low-density lipoproteins increase the expression of intercellular adhesion molecule-1 in human aortic endothelial cells.

Marschang P, Götsch C, Kirchmair R, Kaser S, Kähler CM, Patsch JR.

Atherosclerosis. 2006 May;186(1):101-6. Epub 2005 Aug 24.


Normal development and fertility of knockout mice lacking the tumor suppressor gene LRP1b suggest functional compensation by LRP1.

Marschang P, Brich J, Weeber EJ, Sweatt JD, Shelton JM, Richardson JA, Hammer RE, Herz J.

Mol Cell Biol. 2004 May;24(9):3782-93.

Items per page

Supplemental Content

Loading ...
Support Center